Petras Michael B. Jr.
Executive Chairman
- Shares
- 850,000
- Price
- $18.50
- Value
- $15,725,935
SHC
2 sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
−$24,000,036
0 buyers · 2 sellers
12-month purchases
$0.00
0 distinct insiders
12-month sales
$2,594,335,334
24 distinct insiders
Highlighted alerts
22
0 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
SHC overview: breakout setup, X sentiment and insiders in one page →
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
These securities represent the number of shares of Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations due upon the vesting of 25,657 Restricted Stock Units ("RSUs"), which represents 33% of the RSU awards granted to the Reporting Person on August 7, 2023. These awards were granted pursuant to the terms of RSU agreements under the Sotera Health Company 2020 Omnibus Incentive Plan ("2020 Incentive Plan"). Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. No transaction is being reported on this line. Reported on a previously filed Form 4. These options were granted on March 4, 2024, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest annually in three equal installments commencing on March 2, 2025, subject to the Reporting Person's continued service through each such date. These options were granted on August 7, 2023, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest annually in three equal installments commencing August 5, 2024, subject to the Reporting Person's continued service through each such date. These securities consist of the remaining additional performance-based RSUs that were granted on March 3, 2025, pursuant to the terms of an RSU agreement under the 2020 Incentive Plan. Each additional RSU represents the Reporting Person's right to receive one share of Common Stock, subject to stock price-related performance conditions. These RSUs vest in equal installments on March 3, 2027 and March 3, 2028, subject to performance. These securities consist of the maximum number of additional performance-based RSUs that were granted on March 2, 2026, pursuant to the terms of an RSU agreement under the 2020 Incentive Plan. Each additional RSU represents the Reporting Person's right to receive one share of Common Stock, subject to stock price-related performance conditions. The additional RSUs generally vest annually in 60%, 20% and 20% installments, respectively, commencing March 2027, subject to performance.
Voluntary purchases and sales; administrative noise stays hidden.
Petras Michael B. Jr.
Executive Chairman
Petras Michael B. Jr.
Executive Chairman
Rutz Michael P
President of Sterigenics
WARBURG PINCUS & CO.
Director
WARBURG PINCUS & CO.
Director
GTCR INVESTMENT XI LLC
Director
WARBURG PINCUS & CO.
Director
WARBURG PINCUS & CO.
Director
GTCR INVESTMENT XI LLC
Director
Petras Michael B. Jr.
Chairman & CEO
Petras Michael B. Jr.
Chairman & CEO
Petras Michael B. Jr.
Chairman & CEO
WARBURG PINCUS & CO.
Director
WARBURG PINCUS & CO.
Director
GTCR INVESTMENT XI LLC
Director
WARBURG PINCUS & CO.
Director
WARBURG PINCUS & CO.
Director
GTCR INVESTMENT XI LLC
Director
WARBURG PINCUS & CO.
Director
WARBURG PINCUS & CO.
Director
GTCR INVESTMENT XI LLC
Director
Rutz Michael P
President of Sterigenics
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Aug 17, 2026 | Petras Michael B. Jr. Executive Chairman | Sale | 850,000 | $18.50 | $15,725,935 | |
| Aug 17, 2026 | Petras Michael B. Jr. Executive Chairman | Sale | 294,515 | $18.50 | $5,448,851 | |
| Aug 07, 2026 | Rutz Michael P President of Sterigenics | Sale | 150,000 | $18.84 | $2,825,250 | |
| May 13, 2026 | WARBURG PINCUS & CO. Director | Sale | 19,102,952 | $15.17 | $289,753,576 | |
| May 13, 2026 | WARBURG PINCUS & CO. Director | Sale | 19,102,952 | $15.17 | $289,753,576 | |
| May 13, 2026 | GTCR INVESTMENT XI LLC Director | Sale | 12,735,301 | $15.17 | $193,169,046 | |
| Mar 06, 2026 | WARBURG PINCUS & CO. Director | Sale | 15,000,000 | $15.27 | $229,050,000 | |
| Mar 06, 2026 | WARBURG PINCUS & CO. Director | Sale | 15,000,000 | $15.27 | $229,050,000 | |
| Mar 06, 2026 | GTCR INVESTMENT XI LLC Director | Sale | 10,000,000 | $15.27 | $152,700,000 | |
| Dec 08, 2025 | Petras Michael B. Jr. Chairman & CEO | Sale | 39,243 | $16.45 | $645,547 | |
| Dec 08, 2025 | Petras Michael B. Jr. Chairman & CEO | Sale | 394,861 | $16.45 | $6,495,463 | |
| Dec 08, 2025 | Petras Michael B. Jr. Chairman & CEO | Sale | 315,896 | $16.45 | $5,196,489 | |
| Dec 03, 2025 | WARBURG PINCUS & CO. Director | Sale | 9,720,000 | $16.33 | $158,727,600 | |
| Dec 03, 2025 | WARBURG PINCUS & CO. Director | Sale | 9,720,000 | $16.33 | $158,727,600 | |
| Dec 03, 2025 | GTCR INVESTMENT XI LLC Director | Sale | 6,480,000 | $16.33 | $105,818,400 | |
| Nov 10, 2025 | WARBURG PINCUS & CO. Director | Sale | 18,000,000 | $15.65 | $281,718,000 | |
| Nov 10, 2025 | WARBURG PINCUS & CO. Director | Sale | 18,000,000 | $15.65 | $281,718,000 | |
| Nov 10, 2025 | GTCR INVESTMENT XI LLC Director | Sale | 12,000,000 | $15.65 | $187,812,000 | |
| Sep 05, 2025 | WARBURG PINCUS & CO. Director | Sale | 12,000,000 | $15.11 | $181,332,000 | |
| Sep 05, 2025 | WARBURG PINCUS & CO. Director | Sale | 12,000,000 | $15.11 | $181,332,000 | |
| Sep 05, 2025 | GTCR INVESTMENT XI LLC Director | Sale | 8,000,000 | $15.11 | $120,888,000 | |
| Aug 22, 2025 | Rutz Michael P President of Sterigenics | Sale | 126,611 | $16.38 | $2,074,306 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.